Cover Image
市場調查報告書

眼科用診斷設備:醫療設備的開發平台評估

Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 350921
出版日期 內容資訊 英文 224 Pages
訂單完成後即時交付
價格
Back to Top
眼科用診斷設備:醫療設備的開發平台評估 Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月12日 內容資訊: 英文 224 Pages
簡介

本報告提供眼科用診斷設備的開發中產品調查分析,以各開發階段比較分析為焦點,提供您正在開發開發中產品的主要企業,進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • 眼科用診斷設備概要

第3章 開發中的產品

  • 眼科用診斷設備 - 開發中產品:各開發階段
  • 眼科用診斷設備 - 開發中產品:各市場區隔
  • 眼科用診斷設備 - 開發中產品:各地區
  • 眼科用診斷設備 - 開發中產品:法規別
  • 眼科用診斷設備 - 開發中產品:核准預定日別
  • 眼科用診斷設備 - 進行中的臨床試驗

第4章 眼科用診斷設備 - 正在開發的開發中產品:各企業

  • 眼科用診斷設備企業 - 開發中產品:各開發階段
  • 眼科用診斷設備 - 開發中產品:各開發階段

第5章 眼科用診斷設備企業與產品概要

  • AcuMEMS
  • Aeon Imaging, LLC
  • Arizona State University
  • Avedro, Inc.
  • Baylor College of Medicine
  • BioFormatix, Inc.
  • Bioptigen, Inc.
  • Boston Micromachines Corporation
  • Brockman-Hastings LLC
  • Canon U.S.A., Inc.
  • Cardiff University
  • Case Western Reserve University
  • CeeMax Ophthalmics
  • Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina
  • Chinese University of Hong Kong
  • ChromoLogic LLC
  • Cleveland Clinic Hospital
  • Coland Holdings Company Limited
  • Compact Imaging Inc.
  • DigitalVision, LLC等

第6章 眼科用診斷設備 - 最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0445EPD

GlobalData's Medical Devices sector report, "Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2017" provides an overview of Ophthalmic Diagnostic Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Diagnostic Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ophthalmic Diagnostic Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Diagnostic Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Diagnostic Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Ophthalmic Diagnostic Equipment Overview 15

3 Products under Development 17

  • 3.1 Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 17
  • 3.2 Ophthalmic Diagnostic Equipment - Pipeline Products by Segment 18
  • 3.3 Ophthalmic Diagnostic Equipment - Pipeline Products by Territory 19
  • 3.4 Ophthalmic Diagnostic Equipment - Pipeline Products by Regulatory Path 20
  • 3.5 Ophthalmic Diagnostic Equipment - Pipeline Products by Estimated Approval Date 21
  • 3.6 Ophthalmic Diagnostic Equipment - Ongoing Clinical Trials 22

4 Ophthalmic Diagnostic Equipment - Pipeline Products under Development by Companies 23

  • 4.1 Ophthalmic Diagnostic Equipment Companies - Pipeline Products by Stage of Development 23
  • 4.2 Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 27

5 Ophthalmic Diagnostic Equipment Companies and Product Overview 31

  • 5.1 AcuMEMS Company Overview 31
    • 5.1.1 AcuMEMS Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.2 Aeon Imaging, LLC Company Overview 34
    • 5.2.1 Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.3 Arizona State University Company Overview 35
    • 5.3.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.4 Aston EyeTech Ltd Company Overview 36
    • 5.4.1 Aston EyeTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.5 Avedro Inc Company Overview 38
    • 5.5.1 Avedro Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.6 Bar-Ilan University Company Overview 39
    • 5.6.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.7 Baylor College of Medicine Company Overview 40
    • 5.7.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.8 BioFormatix, Inc. Company Overview 43
    • 5.8.1 BioFormatix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.9 Boston Micromachines Corporation Company Overview 44
    • 5.9.1 Boston Micromachines Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.10 Canon U.S.A. Inc Company Overview 45
    • 5.10.1 Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.11 Cardiff University Company Overview 49
    • 5.11.1 Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.12 Case Western Reserve University Company Overview 50
    • 5.12.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.13 CeeMax Ophthalmics Company Overview 51
    • 5.13.1 CeeMax Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.14 Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Company Overview 52
    • 5.14.1 Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.15 Chinese University of Hong Kong Company Overview 54
    • 5.15.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.16 ChromoLogic LLC Company Overview 55
    • 5.16.1 ChromoLogic LLC Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.17 Cleveland Clinic Hospital Company Overview 56
    • 5.17.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.18 Coland Holdings Limited Company Overview 57
    • 5.18.1 Coland Holdings Limited Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.19 Compact Imaging Inc. Company Overview 59
    • 5.19.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.20 Costruzioni Strumenti Oftalmici Cso Srl Company Overview 60
    • 5.20.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.21 DigitalVision, LLC Company Overview 61
    • 5.21.1 DigitalVision, LLC Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.22 Dioptrix Company Overview 62
    • 5.22.1 Dioptrix Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.23 Duke University Company Overview 63
    • 5.23.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.24 El-Vision Ltd. Company Overview 67
    • 5.24.1 El-Vision Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.25 Epvsensors, LLC Company Overview 68
    • 5.25.1 Epvsensors, LLC Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.26 Eye Care and Cure Company Overview 70
    • 5.26.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.27 eyeMITRA Company Overview 71
    • 5.27.1 eyeMITRA Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.28 Eyenuk Inc. Company Overview 72
    • 5.28.1 Eyenuk Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.29 George Washington University Company Overview 74
    • 5.29.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.30 Glakolens Company Overview 75
    • 5.30.1 Glakolens Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.31 Glaukos Corp Company Overview 76
    • 5.31.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.32 Hadasit Medical Research Services and Development Ltd Company Overview 77
    • 5.32.1 Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.33 Hadassah Medical Center Company Overview 78
    • 5.33.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.34 Heidelberg Engineering GmbH Company Overview 79
    • 5.34.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.35 Heriot-Watt University Company Overview 81
    • 5.35.1 Heriot-Watt University Pipeline Products & Ongoing Clinical Trials Overview 81
  • 5.36 Hong Kong Polytechnic University Company Overview 82
    • 5.36.1 Hong Kong Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.37 iHealthScreen Inc Company Overview 83
    • 5.37.1 iHealthScreen Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • 5.38 Imperial College London Company Overview 85
    • 5.38.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.39 Implandata Ophthalmic Products GmbH Company Overview 86
    • 5.39.1 Implandata Ophthalmic Products GmbH Pipeline Products & Ongoing Clinical Trials Overview 86
  • 5.40 Indian Institute of Technology Bombay Company Overview 90
    • 5.40.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 90
  • 5.41 i-Optics BV Company Overview 91
    • 5.41.1 i-Optics BV Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.42 Iowa State University Company Overview 93
    • 5.42.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.43 iSonic Medical Company Overview 94
    • 5.43.1 iSonic Medical Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.44 John Hopkins University Company Overview 95
    • 5.44.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.45 Konan Medical Inc Company Overview 96
    • 5.45.1 Konan Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.46 Kowa Company Ltd Company Overview 99
    • 5.46.1 Kowa Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
  • 5.47 LaunchPoint Technologies, Inc. Company Overview 100
    • 5.47.1 LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
  • 5.48 Leica Microsystems GmbH Company Overview 101
    • 5.48.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 101
  • 5.49 Lumetrics Inc Company Overview 103
    • 5.49.1 Lumetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 103
  • 5.50 Lumisoft Technologies Pvt Ltd Company Overview 107
    • 5.50.1 Lumisoft Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 107
  • 5.51 MacCure Company Overview 108
    • 5.51.1 MacCure Pipeline Products & Ongoing Clinical Trials Overview 108
  • 5.52 Maculogix, Inc. Company Overview 109
    • 5.52.1 Maculogix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
  • 5.53 Medical University of South Carolina Company Overview 110
    • 5.53.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 110
  • 5.54 Moorfields Eye Hospital NHS Foundation Trust Company Overview 111
    • 5.54.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 111
  • 5.55 Nagasaki University Company Overview 112
    • 5.55.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 112
  • 5.56 National Taiwan University Hospital Company Overview 113
    • 5.56.1 National Taiwan University Hospital Pipeline Products & Ongoing Clinical Trials Overview 113
  • 5.57 National University of Ireland Galway Company Overview 114
    • 5.57.1 National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview 114
  • 5.58 Neuro Kinetics Inc Company Overview 115
    • 5.58.1 Neuro Kinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 115
  • 5.59 Nikon Instruments Inc. Company Overview 116
    • 5.59.1 Nikon Instruments Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
  • 5.60 oDocs Eye Care Ltd Company Overview 117
    • 5.60.1 oDocs Eye Care Ltd Pipeline Products & Ongoing Clinical Trials Overview 117
  • 5.61 OptoQuest Company Overview 119
    • 5.61.1 OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 119
  • 5.62 Optos Plc Company Overview 120
    • 5.62.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 120
  • 5.63 Optovue Inc Company Overview 123
    • 5.63.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 123
  • 5.64 PAIR Technologies LLC Company Overview 124
    • 5.64.1 PAIR Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 124
  • 5.65 Paradigm Medical Industries, Inc. (Inactive) Company Overview 125
    • 5.65.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 125
  • 5.66 RetinalGenix, Inc. Company Overview 126
    • 5.66.1 RetinalGenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
  • 5.67 Retinostics Company Overview 127
    • 5.67.1 Retinostics Pipeline Products & Ongoing Clinical Trials Overview 127
  • 5.68 Rice University Company Overview 128
    • 5.68.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 128
  • 5.69 Rutgers The State University of New Jersey Company Overview 129
    • 5.69.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 129
  • 5.70 Scalar Bioscience, LLC Company Overview 130
    • 5.70.1 Scalar Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 130
  • 5.71 Sheba Medical Center Company Overview 131
    • 5.71.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 131
  • 5.72 Sinoora Inc. Company Overview 132
    • 5.72.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 132
  • 5.73 SOLX Inc Company Overview 133
    • 5.73.1 SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview 133
  • 5.74 Stanford University Company Overview 134
    • 5.74.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 134
  • 5.75 Stellenbosch University Company Overview 135
    • 5.75.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 135
  • 5.76 Structured Eye Ltd Company Overview 136
    • 5.76.1 Structured Eye Ltd Pipeline Products & Ongoing Clinical Trials Overview 136
  • 5.77 Tear Diagno LLC (Inactive) Company Overview 137
    • 5.77.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 137
  • 5.78 The National Digital Research Centre Limited Company Overview 138
    • 5.78.1 The National Digital Research Centre Limited Pipeline Products & Ongoing Clinical Trials Overview 138
  • 5.79 The Wilmer Eye Institute at Johns Hopkins Company Overview 139
    • 5.79.1 The Wilmer Eye Institute at Johns Hopkins Pipeline Products & Ongoing Clinical Trials Overview 139
  • 5.80 Tissot Medical Research SA Company Overview 141
    • 5.80.1 Tissot Medical Research SA Pipeline Products & Ongoing Clinical Trials Overview 141
  • 5.81 University of Arizona Company Overview 142
    • 5.81.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 142
  • 5.82 University of California Berkeley Company Overview 144
    • 5.82.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 144
  • 5.83 University of California Los Angeles Company Overview 146
    • 5.83.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 146
  • 5.84 University of California San Diego Company Overview 147
    • 5.84.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 147
  • 5.85 University of California San Francisco Company Overview 148
    • 5.85.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 148
  • 5.86 University of Edinburgh Company Overview 149
    • 5.86.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 149
  • 5.87 University of Malaya Company Overview 150
    • 5.87.1 University of Malaya Pipeline Products & Ongoing Clinical Trials Overview 150
  • 5.88 University of Pecs Company Overview 151
    • 5.88.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 151
  • 5.89 University of Rochester Company Overview 152
    • 5.89.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 152
  • 5.90 University of South Florida Company Overview 153
    • 5.90.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 153
  • 5.91 University of Valencia Company Overview 154
    • 5.91.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 154
  • 5.92 University of Washington Company Overview 155
    • 5.92.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 155
  • 5.93 VisionQuest Biomedical, LLC Company Overview 156
    • 5.93.1 VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 156
  • 5.94 Visual Pathways, Inc. (Inactive) Company Overview 157
    • 5.94.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 157
  • 5.95 ViVO Smart Medical Devices Ltd Company Overview 159
    • 5.95.1 ViVO Smart Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 159
  • 5.96 Volcano Corp Company Overview 160
    • 5.96.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 160
  • 5.97 Welch Allyn Inc Company Overview 161
    • 5.97.1 Welch Allyn Inc Pipeline Products & Ongoing Clinical Trials Overview 161
  • 5.98 Ziemer Ophthalmic Systems AG Company Overview 162
    • 5.98.1 Ziemer Ophthalmic Systems AG Pipeline Products & Ongoing Clinical Trials Overview 162

6 Ophthalmic Diagnostic Equipment- Recent Developments 164

  • 6.1 Aug 22, 2017: Clinical Study Shows that Retinal Imaging may Detect Signs of Alzheimer's Disease 164
  • 6.2 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 165
  • 6.3 Aug 14, 2017: TearLab Reports Second Quarter and First Half 2017 Financial Results 166
  • 6.4 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 167
  • 6.5 Aug 07, 2017: Revenio Group: Half Year Financial Report January 1-June 30, 2017 167
  • 6.6 Aug 02, 2017: Oclaro Announces Fourth Quarter and Fiscal Year 2017 Financial Results 169
  • 6.7 Aug 02, 2017: Oclaro Appoints Global Communications Services Executive to Board of Directors 170
  • 6.8 Aug 01, 2017: Notal Vision Welcomes Roni Amiel as Chief Information Officer 170
  • 6.9 Jul 27, 2017: Breakthrough research on stem cell-derived retinal organoid imaging offers real-time insights into the developmental origins of blinding eye diseases 171
  • 6.10 Jul 24, 2017: Notal Vision Names Jim Long as Chief Financial Officer 172
  • 6.11 Jul 18, 2017: Donald J. Zurbay Joins Avedro's Board of Directors 173

7 Appendix 220

  • 7.1 Methodology 221
  • 7.2 About GlobalData 224
  • 7.3 Contact Us 224
  • 7.4 Disclaimer 224

List of Tables

1.1 List of Tables

  • Table 1: Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 17
  • Table 2: Ophthalmic Diagnostic Equipment - Pipeline Products by Segment 18
  • Table 3: Ophthalmic Diagnostic Equipment - Pipeline Products by Territory 19
  • Table 4: Ophthalmic Diagnostic Equipment - Pipeline Products by Regulatory Path 20
  • Table 5: Ophthalmic Diagnostic Equipment - Pipeline Products by Estimated Approval Date 21
  • Table 6: Ophthalmic Diagnostic Equipment - Ongoing Clinical Trials 22
  • Table 7: Ophthalmic Diagnostic Equipment Companies - Pipeline Products by Stage of Development 23
  • Table 8: Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 27
  • Table 9: AcuMEMS Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 10: IOP Sensor - Anterior Chamber - Product Status 31
  • Table 11: IOP Sensor - Anterior Chamber - Product Description 31
  • Table 12: IOP Sensor - Posterior Chamber - Product Status 32
  • Table 13: IOP Sensor - Posterior Chamber - Product Description 32
  • Table 14: iSense System - Product Status 32
  • Table 15: iSense System - Product Description 33
  • Table 16: Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 17: Laser Scanning Digital Camera Stimulator - Product Status 34
  • Table 18: Laser Scanning Digital Camera Stimulator - Product Description 34
  • Table 19: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 20: Hand-Held Tonometer - Glaucoma - Product Status 35
  • Table 21: Hand-Held Tonometer - Glaucoma - Product Description 35
  • Table 22: Aston EyeTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 23: Autorefractor - Product Status 36
  • Table 24: Autorefractor - Product Description 36
  • Table 25: Lensmeter - Desktop Version - Product Status 37
  • Table 26: Lensmeter - Desktop Version - Product Description 37
  • Table 27: Avedro Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 28: Brillouin Scanning Microscope - Product Status 38
  • Table 29: Brillouin Scanning Microscope - Product Description 38
  • Table 30: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 31: Intraocular Pressure Monitoring Device - Home Use - Product Status 39
  • Table 32: Intraocular Pressure Monitoring Device - Home Use - Product Description 39
  • Table 33: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 34: HOCD Device - Product Status 40
  • Table 35: HOCD Device - Product Description 40
  • Table 36: Baylor College of Medicine - Ongoing Clinical Trials Overview 41
  • Table 37: HOCD Device - Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients with and without Glaucoma 42
  • Table 38: BioFormatix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 39: VirtualEye Perimeter - Product Status 43
  • Table 40: VirtualEye Perimeter - Product Description 43
  • Table 41: Boston Micromachines Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 42: Next Generation Adaptive Optics Scanning Laser Ophthalmoscope - Product Status 44
  • Table 43: Next Generation Adaptive Optics Scanning Laser Ophthalmoscope - Product Description 44
  • Table 44: Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 45: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) Based System - Product Status 45
  • Table 46: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) Based System - Product Description 45
  • Table 47: SPOCT HR - Product Status 46
  • Table 48: SPOCT HR - Product Description 46
  • Table 49: Canon U.S.A. Inc - Ongoing Clinical Trials Overview 47
  • Table 50: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) Based System - High Resolution Retinal Imaging in Patients with Inherited Retinal Degenerations 48
  • Table 51: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) Based System - Photoreceptor Structure in A Phase 2 Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants with Retinitis Pigmentosa Using Rates of Change in Cone Spacing and Density 48
  • Table 52: Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 53: Retinal Densitometer - Product Status 49
  • Table 54: Retinal Densitometer - Product Description 49
  • Table 55: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 56: Two-photon Ophthalmoscope - Product Status 50
  • Table 57: Two-photon Ophthalmoscope - Product Description 50
  • Table 58: CeeMax Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 59: In-Home Tonometer - Product Status 51
  • Table 60: In-Home Tonometer - Product Description 51
  • Table 61: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 62: Lente Sensora - Product Status 52
  • Table 63: Lente Sensora - Product Description 52
  • Table 64: Sensing Contact Lens - Product Status 53
  • Table 65: Sensing Contact Lens - Product Description 53
  • Table 66: Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 67: Automatic Retinal Image Analysis System - Product Status 54
  • Table 68: Automatic Retinal Image Analysis System - Product Description 54
  • Table 69: ChromoLogic LLC Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 70: Ocular Flare Meter - Product Status 55
  • Table 71: Ocular Flare Meter - Product Description 55
  • Table 72: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 73: Interoperative OCT System - Product Status 56
  • Table 74: Interoperative OCT System - Product Description 56
  • Table 75: Coland Holdings Limited Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 76: Ophthalmic Laser Scanning Fundus Photographic Instrument - Product Status 57
  • Table 77: Ophthalmic Laser Scanning Fundus Photographic Instrument - Product Description 57
  • Table 78: Portable Fundus Camera - Product Status 58
  • Table 79: Portable Fundus Camera - Product Description 58
  • Table 80: Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 81: MRO Optical Imaging Sensor - Product Status 59
  • Table 82: MRO Optical Imaging Sensor - Product Description 59
  • Table 83: Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 84: MD-SD-OCT Instrument - Product Status 60
  • Table 85: MD-SD-OCT Instrument - Product Description 60
  • Table 86: DigitalVision, LLC Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 87: VisionOptimizer - Product Status 61
  • Table 88: VisionOptimizer - Product Description 61
  • Table 89: Dioptrix Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 90: Hawk Eye - Product Status 62
  • Table 91: Hawk Eye - Product Description 62
  • Table 92: Duke University Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 93: HH - SDOCT - Product Status 63
  • Table 94: HH - SDOCT - Product Description 63
  • Table 95: Microscope Integrated OCT System - Product Status 64
  • Table 96: Microscope Integrated OCT System - Product Description 64
  • Table 97: Duke University - Ongoing Clinical Trials Overview 65
  • Table 98: Microscope Integrated OCT System - Intraoperative OCT Guidance of Intraocular Surgery 66
  • Table 99: El-Vision Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 100: OcuTest - Product Status 67
  • Table 101: OcuTest - Product Description 67
  • Table 102: Epvsensors, LLC Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 103: Retinal Photometer - Product Status 68
  • Table 104: Retinal Photometer - Product Description 68
  • Table 105: Tactile Tonometer TT001 - Product Status 69
  • Table 106: Tactile Tonometer TT001 - Product Description 69
  • Table 107: Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 108: Diagnostic Device - Eye Alignment - Product Status 70
  • Table 109: Diagnostic Device - Eye Alignment - Product Description 70
  • Table 110: eyeMITRA Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 111: eyeMITRA Device - Product Status 71
  • Table 112: eyeMITRA Device - Product Description 71
  • Table 113: Eyenuk Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 114: EyeMark - Product Status 72
  • Table 115: EyeMark - Product Description 72
  • Table 116: EyeSeeAMD - Product Status 73
  • Table 117: EyeSeeAMD - Product Description 73
  • Table 118: George Washington University Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 119: Amplified Bimorph Scanning Mirror System - Product Status 74
  • Table 120: Amplified Bimorph Scanning Mirror System - Product Description 74
  • Table 121: Glakolens Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 122: IOP Sensor - Product Status 75
  • Table 123: IOP Sensor - Product Description 75
  • Table 124: Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 125: IOP Sensor System - Product Status 76
  • Table 126: IOP Sensor System - Product Description 76
  • Table 127: Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 128: Automated Visual Acuity Device - Product Status 77
  • Table 129: Automated Visual Acuity Device - Product Description 77
  • Table 130: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 131: Optic Neuritis Visual Test - Product Status 78
  • Table 132: Optic Neuritis Visual Test - Product Description 78
  • Table 133: Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 134: Cataract And Refractive Imaging Platform - Product Status 79
  • Table 135: Cataract And Refractive Imaging Platform - Product Description 79
  • Table 136: SPECTRALIS OCT2 Module - OCT Angiography - Product Status 80
  • Table 137: SPECTRALIS OCT2 Module - OCT Angiography - Product Description 80
  • Table 138: Heriot-Watt University Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 139: Non-Invasive Cataract Diagnostic Tool - Product Status 81
  • Table 140: Non-Invasive Cataract Diagnostic Tool - Product Description 81
  • Table 141: Hong Kong Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 142: Diabetic Retinopathy Detection and Monitoring System - Product Status 82
  • Table 143: Diabetic Retinopathy Detection and Monitoring System - Product Description 82
  • Table 144: iHealthScreen Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 145: Age Related Macular Degeneration Screening Device - Product Status 83
  • Table 146: Age Related Macular Degeneration Screening Device - Product Description 83
  • Table 147: Diabetic Retinopathy Screening System - Product Status 84
  • Table 148: Diabetic Retinopathy Screening System - Product Description 84
  • Table 149: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 150: Intraocular Wireless Pressure Sensing Implant - Product Status 85
  • Table 151: Intraocular Wireless Pressure Sensing Implant - Product Description 85
  • Table 152: Implandata Ophthalmic Products GmbH Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 153: ARGOS-EO - Product Status 86
  • Table 154: ARGOS-EO - Product Description 86
  • Table 155: ARGOS-IO - Product Status 87
  • Table 156: ARGOS-IO - Product Description 87
  • Table 157: Implandata Ophthalmic Products GmbH - Ongoing Clinical Trials Overview 88
  • Table 158: ARGOS-IO - A Prospective Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of ARGOS-IO System in Patients Undergoing Implantation of a Boston Keratoprosthesis (BKPro) 89
  • Table 159: ARGOS-IO - A Prospective, Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of the ARGOS-IO System in Patients with Primary Open Angle Glaucoma (POAG) 89
  • Table 160: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 161: Glaucoma Screener - Product Status 90
  • Table 162: Glaucoma Screener - Product Description 90
  • Table 163: i-Optics BV Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 164: 1KHz Retina Tracker - Product Status 91
  • Table 165: 1KHz Retina Tracker - Product Description 91
  • Table 166: Superresolution Image Enhancement - Product Status 92
  • Table 167: Superresolution Image Enhancement - Product Description 92
  • Table 168: Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 169: Glaucoma Detection Device - Product Status 93
  • Table 170: Glaucoma Detection Device - Product Description 93
  • Table 171: iSonic Medical Pipeline Products & Ongoing Clinical Trials Overview 94
  • Table 172: Telemedical Homecare Tonometer - Product Status 94
  • Table 173: Telemedical Homecare Tonometer - Product Description 94
  • Table 174: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 175: Fundus Imaging System - Product Status 95
  • Table 176: Fundus Imaging System - Product Description 95
  • Table 177: Konan Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 178: Bionocular Analytic Dynamic Pupillometer - Product Status 96
  • Table 179: Bionocular Analytic Dynamic Pupillometer - Product Description 96
  • Table 180: Konan Medical Inc - Ongoing Clinical Trials Overview 97
  • Table 181: Bionocular Analytic Dynamic Pupillometer - The Detection of Glaucoma Using Pupillography 98
  • Table 182: Kowa Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
  • Table 183: VX-10a - Fundus Autofluorescence - Product Status 99
  • Table 184: VX-10a - Fundus Autofluorescence - Product Description 99
  • Table 185: LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
  • Table 186: Intraocular Pressure Sensor - Product Status 100
  • Table 187: Intraocular Pressure Sensor - Product Description 100
  • Table 188: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 101
  • Table 189: DI-SDOCT Imaging System - Product Status 101
  • Table 190: DI-SDOCT Imaging System - Product Description 101
  • Table 191: SDOCT Scanner - Product Status 102
  • Table 192: SDOCT Scanner - Product Description 102
  • Table 193: Lumetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 103
  • Table 194: Axial Length Eye Measurement System - Product Status 103
  • Table 195: Axial Length Eye Measurement System - Product Description 103
  • Table 196: Fundus Camera - Product Status 104
  • Table 197: Fundus Camera - Product Description 104
  • Table 198: Lumetrics Inc - Ongoing Clinical Trials Overview 105
  • Table 199: Fundus Camera - The Impact of Telemedicine System to the Diagnosis and Treatment of Diabetes Retinopathy in Rural Canton 106
  • Table 200: Lumisoft Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 107
  • Table 201: Digital Slit Lamp - Product Status 107
  • Table 202: Digital Slit Lamp - Product Description 107
  • Table 203: MacCure Pipeline Products & Ongoing Clinical Trials Overview 108
  • Table 204: Opthalmic Diagnostic Device - Macular Degeneration - Product Status 108
  • Table 205: Opthalmic Diagnostic Device - Macular Degeneration - Product Description 108
  • Table 206: Maculogix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
  • Table 207: AdaptDx - AMD - Product Status 109
  • Table 208: AdaptDx - AMD - Product Description 109
  • Table 209: Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 110
  • Table 210: Retinal Disease Evaluation Device - Product Status 110
  • Table 211: Retinal Disease Evaluation Device - Product Description 110
  • Table 212: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 111

List of Figures

1.2 List of Figures

  • Figure 1: Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 17
  • Figure 2: Ophthalmic Diagnostic Equipment - Pipeline Products by Segment 18
  • Figure 3: Ophthalmic Diagnostic Equipment - Pipeline Products by Territory 19
  • Figure 4: Ophthalmic Diagnostic Equipment - Pipeline Products by Regulatory Path 20
  • Figure 5: Ophthalmic Diagnostic Equipment - Pipeline Products by Estimated Approval Date 21
  • Figure 6: Ophthalmic Diagnostic Equipment - Ongoing Clinical Trials 22
Back to Top